Pancreatic Cancer Vaccine: Patients Survive 6+ Years

A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive.

For a disease with just 13% five-year survival, this breakthrough offers real hope.